These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18555544)

  • 1. Therapeutic advantage of teriparatide in very elderly patients with proximal femoral fractures: a functional and BMD analysis.
    Sheng OC; Wu WT; Peng CH; Yao TK; Chen IH; Wang JH; Yeh KT
    BMC Musculoskelet Disord; 2024 Apr; 25(1):288. PubMed ID: 38614984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances and Unmet Needs in the Therapeutics of Bone Fragility.
    Ramchand SK; Seeman E
    Front Endocrinol (Lausanne); 2018; 9():505. PubMed ID: 30237785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in the aging male: treatment options.
    Tuck SP; Datta HK
    Clin Interv Aging; 2007; 2(4):521-36. PubMed ID: 18225452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriparatide as Treatment for Severe Osteoporosis in Lung Transplant Recipients.
    Raven LM; Goodall L; Center JR; Muir CA
    JCEM Case Rep; 2024 Mar; 2(3):luae026. PubMed ID: 38495394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematical mutational analysis of teriparatide on anti-osteoporosis activity by alanine scanning.
    Liang H; Shen H; Zheng M; Shi Y; Li X
    Bioorg Med Chem Lett; 2024 May; 104():129732. PubMed ID: 38583785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Teriparatide Delivery by-virtue-of Novel Drug Delivery Approaches for the Management of Osteoporosis.
    Salave S; Rana D; Prayag K; Shah S; Rawat G; Sharma N; Jindal AB; Patel R; Benival D
    Crit Rev Ther Drug Carrier Syst; 2023; 40(5):93-123. PubMed ID: 37522550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective strategies for pregnancy and lactation-associated osteoporosis: teriparatide use in focus.
    Ali DS; Khan AA; Brandi ML
    Endocrine; 2024 Jul; ():. PubMed ID: 39008200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone damage after chemotherapy for lymphoma: a real-world experience.
    Mancuso S; Scaturro D; Santoro M; Di Gaetano G; Vitagliani F; Falco V; Siragusa S; Gonnelli S; Mauro GL
    BMC Musculoskelet Disord; 2021 Dec; 22(1):1024. PubMed ID: 34876084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product.
    Fernández-Carneado J; Vallès-Miret M; Arrastia-Casado S; Almazán-Moga A; Macias MJ; Martin-Malpartida P; Vilaseca M; Díaz-Lobo M; Vazquez M; Sanahuja RM; Gambús G; Ponsati B
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The persistence and the reasons for discontinuation of daily teriparatide self-injection (dTPTD); difference between inpatients and outpatients when started dTPTD].
    Nihon Ronen Igakkai Zasshi; 2024; 61(1):87-89. PubMed ID: 38583976
    [No Abstract]   [Full Text] [Related]  

  • 11. Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot study.
    Diamond TH; Golombick T; Manoharan A; Ramakrishna R; Bryant C
    Am J Hematol; 2020 Oct; 95(10):E272-E276. PubMed ID: 32602126
    [No Abstract]   [Full Text] [Related]  

  • 12. Multilevel "fish-vertebra" sign in a patient with idiopathic osteoporosis.
    Vasiliadis AV; Valanos I; Valanos N; Mpeletsiotis A
    Clin Case Rep; 2021 Jun; 9(6):e04250. PubMed ID: 34194779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial.
    Takada J; Dinavahi R; Miyauchi A; Hamaya E; Hirama T; Libanati C; Nakamura Y; Milmont CE; Grauer A
    J Bone Miner Metab; 2020 May; 38(3):310-315. PubMed ID: 31707465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis.
    Hagino H; Takano T; Fukunaga M; Shiraki M; Nakamura T; Matsumoto T
    J Bone Miner Metab; 2013 Mar; 31(2):183-9. PubMed ID: 23129180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide.
    Maugeri D; Russo E; Luca S; Leotta C; Mamazza G; Sorace R; Rizzotto M; Manuele S; Fiore V; Taverna G; Castiglia B; Calitro M
    Arch Gerontol Geriatr; 2009; 49(1):35-8. PubMed ID: 18555544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.